
CC-115 hydrochloride
CAS No. 1300118-55-1
CC-115 hydrochloride ( —— )
产品货号. M11206 CAS No. 1300118-55-1
一种新型 mTOR 和 DNA-PK 双重抑制剂,IC50 分别为 21 nM 和 13 nM。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
500MG | ¥13422 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称CC-115 hydrochloride
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述一种新型 mTOR 和 DNA-PK 双重抑制剂,IC50 分别为 21 nM 和 13 nM。
-
产品描述A novel dual inhibitor of mTOR and DNA-PK with IC50 of 21 nM and 13 nM, respectively; blocks both mTORC1(pS6) and mTORC2(pAktS473) signaling in PC-3 cancer cells, in vitro and in vivo; exhibits dose-dependent efficacy in tumor xenograft models.Blood Cancer Phase 1 Clinical.
-
体外实验CC-115 inhibits PC-3 cells proliferation with an IC50 of 138 nM. In a kinase selectivity assessment against a panel of 250 protein kinases at 3 μM, only one kinase other than mTOR kinase is identified with more than 50% inhibition (cFMS 57%, IC50=2.0 μM). Of the PI3K related kinases (PIKKs) tested, CC-115 proves to be equipotent against DNA PK (IC50=15 nM) and demonstrates 40 to >1000 fold selectivity against the remaining PIKKs tested; PI3K-alpha (IC50=0.85 μM), ATR (50% inhibition at 30 μM) and ATM (IC50>30 μM). The IC50 values for CC-115 are >10 μM against a panel of CYP enzymes and >33 μM for the hERG (human ether-a-go-go-related gene) ion channel. When screened in a single point assay at 10 μM against a Cerep receptor and enzyme panel only one target is inhibited >50% (PDE3, IC50=0.63 μM).
-
体内实验CC-115 hydrochloride shows good in vivo PK profiles across multiple species with 53%, 76% and ~100% oral bioavailability in mouse, rat and dog, respectively. CC-115 is tested at lower doses of 0.25, 0.5 and 1 mg/kg bid or 1 mg/kg qd, with observed corresponding tumor volume reductions of 46%, 57%, 66% and 57% respectively. CC-115 sustains inhibition though 24 hours. At the 1 mg/kg dose CC-115 shows significant inhibition at 1 and 3 hours, CC-115 demonstrating inhibition through 10 hours. CC-115 is evaluated using both once (qd) and twice (bid) daily dosing schedules.
-
同义词——
-
通路PI3K/Akt/mTOR signaling
-
靶点mTOR
-
受体mTOR
-
研究领域Cancer
-
适应症Blood cancer
化学信息
-
CAS Number1300118-55-1
-
分子量372.8122
-
分子式C16H17ClN8O
-
纯度>98% (HPLC)
-
溶解度DMSO: ≥ 30 mg/mL
-
SMILESCCN1C(=O)CNC2=NC=C(N=C21)C3=C(N=C(C=C3)C4=NC=NN4)C.Cl
-
化学全称Pyrazino[2,3-b]pyrazin-2(1H)-one, 1-ethyl-3,4-dihydro-7-[2-methyl-6-(1H-1,2,4-triazol-5-yl)-3-pyridinyl]-, hydrochloride (1:x)
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Mortensen DS, et al. J Med Chem. 2015 Jul 23;58(14):5599-608.
2. Thijssen R, et al. Blood. 2016 Jul 28;128(4):574-83.
产品手册




关联产品
-
MTI-31
MTI-31(LXI-15029,mTOR 抑制剂-31)是一种新型有效的选择性 mTORC1/mTORC2 抑制剂,Kd 为 0.2 nM (mTOR)。
-
NV-128
NV-128 (LY-303511) 是一种新型异黄酮衍生物,可抑制 mTOR 并促进不依赖 caspase 的细胞死亡。
-
PI3Kα/mTOR-IN-1
PI3Kα/mTOR-IN-1 是一种有效的 PI3Kα/mTOR 双重抑制剂,在细胞实验中对 PI3Kα 的 IC50 值为 7 nM,在体外酶实验中对 mTOR 和 PI3Kα 的 Ki 值分别为 10.6 nM 和 12.5 nM。